Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Pseudomonas aeruginosa Infections

A Pseudomonas aeruginosa (P. aeruginosa) airway infection is one of the predominant causes contributing to the high morbidity and mortality rates in cystic fibrosis (CF) patients. The emergence of antibiotic resistant P. aeruginosa strains has led to an urgent need for new therapeutic approaches. Ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Camens, Sophie, Liu, Sha, Hon, Karen, Bouras, George Spyro, Psaltis, Alkis James, Wormald, Peter-John, Vreugde, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464757/
https://www.ncbi.nlm.nih.gov/pubmed/34576896
http://dx.doi.org/10.3390/microorganisms9092001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464757/
https://www.ncbi.nlm.nih.gov/pubmed/34576896
http://dx.doi.org/10.3390/microorganisms9092001

Ejemplares similares